We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD (MeMAGEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03247218
Recruitment Status : Unknown
Verified October 2019 by Dr Koren Ariel, HaEmek Medical Center, Israel.
Recruitment status was:  Recruiting
First Posted : August 11, 2017
Last Update Posted : November 1, 2019
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : December 31, 2020